A Phase II Study on Immunogenicity and Safety of MVA-BN® (IMVAMUNE™) Smallpox Vaccine in Subjects With Atopic Dermatitis
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Richard N Greenberg, M.D.
University of Kentucky School of Medicine
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
22 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hospital Juárez de México
Magdalena de las Salinas, CP, Mexico
- Instituto Dermatologico de Jalisco "dr. Jose Barba Rubio"
Guadalajara, Jalisco, Mexico
- Cifbiotec (centro de Investigacion Farmacologica Y Biotecnologica)
Mexico City, Mexico
- Hospital General de México
Mexico City, Mexico
- Hospital Regional Lic. Adolfo Lopez Mateos. Issste Ciudad de Mexico
Mexico City, Mexico
- Centro Regional de Alergia E Inmunología Clínica del Hospital Universitario "dr. José Eleuterio González"
Monterrey, Mexico
- Hospital Angel Leañol, Dermatology
Zapopan, Jalisco, Mexico
- Alta Clinical Research Llc
Tucson, Arizona, United States
- Burke Pharmaceutical Research
Hot Springs, Arkansas, United States
- Rx Clinical Research, Inc.
Garden Grove, California, United States
- Solano Clinical Research
Vallejo, California, United States
- Northwestern University
Chicago, Illinois, United States
- Adult & Pediatric Dermatology Pc
Overland Park, Kansas, United States
- University of Kentucky Medical Center
Lexington, Kentucky, United States
- Saint Louis University
St Louis, Missouri, United States
- Sundance Clinical Research
St Louis, Missouri, United States
- Meridian Clinical Research
Omaha, Nebraska, United States
- Academic Dermatology Associates
Albuquerque, New Mexico, United States
- Dermatology Associates of Rochester
Rochester, New York, United States
- Oregon Dermatology & Research Center
Portland, Oregon, United States
- Dermatology Treatment & Research Center
Dallas, Texas, United States
- Dermatology Clinical Research
San Antonio, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jul 2006
- Primary completion
- 30 Nov 2009
- Completion
- 30 Apr 2010
- Last update posted
- 9 Jan 2019
- Registered enrollment
- 632
- Registry id
- NCT00316602
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.